Additionally, studies have shown that levels of Eotaxin-1 are associated with metabolic disorders such as insulin resistance, impaired glucose tolerance and abnormal lipid metabolism, which are all risk factors for the development of NAFLD (38). The gene discussed is CCL11; the disease is metabolic dysfunction-associated steatotic liver disease.